絞り込み

17057

広告

Clinical variables and biomarkers in prediction of cognitive impairment in patients with newly diagnosed Parkinson's disease: a cohort study.

著者 Schrag A , Siddiqui UF , Anastasiou Z , Weintraub D , Schott JM
Lancet Neurol.2016 Nov 17 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (105view , 0users)

Full Text Sources

Medical

Miscellaneous

Parkinson's disease is associated with an increased incidence of cognitive impairment and dementia. Predicting who is at risk of cognitive decline early in the disease course has implications for clinical prognosis and for stratification of participants in clinical trials. We assessed the use of clinical information and biomarkers as predictive factors for cognitive decline in patients with newly diagnosed Parkinson's disease.
PMID: 27866858 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード